Loading the section
Prices delayed by 15 minutes
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 16, 2026 | 64.48 | 65.67 | 64.34 | 64.73 | 2m |
| September 15, 2026 | 65.78 | 65.78 | 63.85 | 64.45 | 2m |
| September 14, 2026 | 66.27 | 66.88 | 65.72 | 66.41 | 1m |
| September 11, 2026 | 65.96 | 66.05 |
Based on reports through December 31, 2025
BioMarin treats rare inherited diseases — where patients are few and no treatment existed at all.
The rare disease market works unlike the ordinary one: patients number in thousands rather than millions, but there are no competitors and a course costs hundreds of thousands. Diagnosis is genetic, so a patient can be found directly and no large sales force is needed.
The main product of recent years is a drug for achondroplasia, a bone growth disorder in children: it lets a child grow closer to normal, and treatment lasts years. The rest of the portfolio is enzyme replacement therapy for other rare syndromes. Risks: insurer decisions on covering expensive treatment, competition and trial outcomes. The company pays no dividend.
Address:105 DIGITAL DRIVE, NOVATO, CA, 94949, US
| 1.1bn |
| PFEPfizer, Inc. | 27.56 | −30.80 % | 949m |
| ABTAbbott Laboratories | 102.50 | +26.40 % | 833m |
| VRTXVertex Pharmaceuticals Incorporated | 506.37 | −1.93 % | 553m |
| BMYBristol-Myers Squibb Company | 62.62 | −0.35 % | 539m |
| 65.29 |
| 65.68 |
| 2m |
| September 10, 2026 | 64.41 | 65.59 | 63.57 | 65.51 | 2m |
| September 09, 2026 | 63.83 | 65.33 | 63.64 | 64.41 | 2m |
| September 08, 2026 | 65.24 | 66.26 | 64.01 | 64.63 | 1m |
| September 04, 2026 | 65.79 | 66.64 | 65.52 | 66.53 | 2m |
| September 03, 2026 | 67.30 | 67.70 | 66.32 | 66.43 | 1m |
| September 02, 2026 | 65.00 | 67.20 | 64.99 | 66.97 | 3m |
| September 01, 2026 | 65.54 | 66.02 | 64.49 | 64.84 | 2m |
| August 31, 2026 | 65.95 | 66.30 | 64.33 | 65.23 | 2m |
| August 28, 2026 | 64.99 | 65.08 | 64.07 | 64.67 | 1m |
| August 27, 2026 | 65.28 | 65.92 | 64.83 | 65.29 | 1m |
| August 26, 2026 | 65.62 | 66.53 | 65.33 | 65.61 | 2m |
| August 25, 2026 | 65.03 | 66.36 | 65.02 | 66.12 | 1m |
| August 24, 2026 | 66.57 | 67.18 | 64.71 | 65.07 | 2m |
| August 21, 2026 | 67.55 | 68.34 | 66.52 | 66.70 | 2m |
| August 20, 2026 | 68.11 | 68.75 | 67.57 | 67.68 | 1m |
| August 19, 2026 | 68.17 | 69.62 | 67.75 | 69.33 | 2m |